FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

PEGINTRON (peginterferon alfa-2b) Injection
Status: Discontinuation
»Therapeutic Categories: Antiviral; Oncology

Merck Sharp & Dohme Corp. (New 09/12/2019)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
PEGINTRON injection (peginterferon alfa-2b) 50 mcg per 0.5 mL; box containing one 50 mcg per 0.5 mL vial of PEGINTRON Powder for Injection and one 5 mL vial of Diluent (Sterile Water for Injection USP), 2 BD Safety Lok syringes with a safety sleeve and 2 alcohol swabs (NDC 00085-4353-01) 09/12/2019 To be discontinued on or near May 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English